#Stemness
TOX maintains stemness circuits that sustain longevity and multipotency of progenitor CD4+ T cells in chronic infection @cp-immunity.bsky.social @ejohnwherry.bsky.social @i3h-upenn.bsky.social
www.cell.com/immunity/ful...
November 17, 2026 at 5:55 PM
Online now: The transcription factor TOX maintains stemness circuits that sustain longevity and multipotency of progenitor CD4+ T cells in chronic infection
The transcription factor TOX maintains stemness circuits that sustain longevity and multipotency of progenitor CD4+ T cells in chronic infection
Understanding the molecular circuitry controlling CD4+ TEX cell differentiation may provide opportunities to harness CD4+ T cell help and promote clearance of chronic viral infections and tumors. Lundh et al. find that TOX configures the transcriptional and epigenetic landscape of CD4+ Tpex cells, thus enabling differentiation and survival of CD4+ TEX cell responses.
dlvr.it
November 17, 2026 at 8:55 PM
A study reveals that TCF1+ T cells in chronic diseases like autoimmunity and infections display stemness driven by LEF1 and niche factors, indicating TCF1 alone doesn't define T cell stemness. PMID:42385703, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9 #Medsky #RNA 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
No description available
www.cell.com
November 13, 2026 at 12:00 PM
WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling
WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling
Upregulated WDR76 recruits USP14 to stabilize CBX5, promoting nuclear liquid-liquid phase separation and DNA co-condensation. This drives heterochromatin-associated chromatin remodeling and stemness-related transcriptional programs, thereby enhancing HCC stemness, tumor progression, and reduced lenvatinib sensitivity. Conversely, siWDR7-loaded nanoparticles disrupt this axis, suppress tumor growth, and enhance lenvatinib efficacy. ABSTRACT Hepatocellular carcinoma (HCC) is characterized by high recurrence, metastasis, and therapeutic resistance, with cancer stem cells (CSCs) contributing substantially to these malignant features. In this study, we identify WD repeat-containing protein 76 (WDR76) as a key oncofetal regulator of liver cancer stemness. Transcriptomic profiling of an in vitro hepatocyte differentiation model revealed that WDR76 is highly expressed in embryonic stem cells, suppressed during hepatocyte maturation, and aberrantly reactivated in HCC. Clinically, WDR76 upregulation correlated with poor differentiation, advanced stage, and reduced patient survival. Functional assays demonstrated that WDR76 enhances CSC-like properties, including self-renewal, invasion, and lenvatinib resistance, while suppressing hepatocytic differentiation. Mechanistically, WDR76 recruits the deubiquitinase USP14 to stabilize the chromatin-binding protein CBX5 by preventing its ubiquitination and degradation. Stabilized CBX5 undergoes liquid-liquid phase separation, promoting heterochromatin condensation and chromatin reprogramming, thereby activating stemness-associated genes. Loss-and gain-of-function studies confirmed CBX5 as an essential downstream effector of WDR76 in driving HCC stemness and tumor progression. Finally, siRNA-loaded nanoparticles targeting WDR76 synergized with lenvatinib to suppress tumor growth in preclinical models. Together, these findings establish a WDR76-USP14-CBX5 axis as a pivotal pathway sustaining CSC phenotypes and nominate WDR76 as a promising diagnostic and therapeutic target in HCC.
advanced.onlinelibrary.wiley.com
November 16, 2026 at 12:03 PM
Findings from a study in @advancedportfolio.bsky.social support an Epstein–Barr virus (#EBV)-associated MIF–SPP1 #macrophage–#tumor/#TCell crosstalk model linking stemness-associated epithelial phenotypes with immune dysfunction and adverse clinical outcomes.

#OpenAccess | https://bit.ly/4iyKPfO
November 13, 2026 at 1:54 PM
RRIDs were included in this in Cell Death Discovery paper. Thanks for making your methods matter! #OpenResearch #reproducibility #OpenScience
Wnt signaling-mediated activation of cancer cell stemness in thoracic SMARCA4-deficient undifferentiated tumor cells - Cell Death Discovery
Read the full paper: Wnt signaling-mediated activation of cancer cell stemness in thoracic SMARCA4-deficient undifferentiated tumor cells
doi.org
November 16, 2026 at 8:00 AM
LEF1 and other niche factors, alongside TCF1, play critical roles in defining T cell stemness in chronic diseases, revealing a more complex stem-like T cell landscape. PMID:42385703, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
No description available
www.cell.com
November 16, 2026 at 12:00 PM
The authors included RRIDs in their in Cells & Development paper! We value the author's support of reproducibility. #OpenResearch #BetterScience #OpenScience
Hedgehog signaling is hampered by inhibition of cholesterol biosynthesis: The GLI1-DNMT1 cooperativity is a critical factor in controlling stemness and EMT in glioblastoma cells
Read the full paper: Hedgehog signaling is hampered by inhibition of cholesterol biosynthesis: The GLI1-DNMT1 cooperativity is a critical factor in controlling stemness and EMT in glioblastoma cells
doi.org
November 15, 2026 at 8:00 AM
In chronic conditions like autoimmunity and infection, T cell stemness relies on LEF1 and niche factors, revealing TCF1's limitations in defining stem T cell subsets. Insights deepen understanding of T cell… PMID:42385703, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
No description available
www.cell.com
November 19, 2026 at 4:00 AM
#Chemoresistance undermines #ColorectalCancer therapy.

YTHDF1 drives stemness & drug resistance by promoting #NOTCH1 translation, while its inhibition restores chemosensitivity, highlighting it as a potential #TherapeuticTarget.

#STTT #OpenAccess: doi.org/10.1038/s413...
November 11, 2026 at 3:15 PM
Online now: Senescent T cells within the tumor microenvironment are a potent driver for tumor growth, stemness, and chemotherapy resistance
Senescent T cells within the tumor microenvironment are a potent driver for tumor growth, stemness, and chemotherapy resistance
Zhang et al. identify that senescent T (Tsen) cells accumulate within tumors and drive tumor growth, metastasis, stemness, and chemotherapy resistance. Mechanistically, lipid-enriched Tsen SASPs reprogram tumor lipid metabolism and activate STAT1/STAT3 signaling. Targeting Tsen cells or their metabolic crosstalk with tumor cells suppresses tumor progression and enhances therapeutic efficacy.
dlvr.it
November 10, 2026 at 8:19 PM
LEF1 and niche factors shape T cell stemness in chronic disease, revealing TCF1^hi cells are diverse and not solely define stem T cell pools in autoimmunity and chronic infection. PMID:42385703, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9 #Medsky #Pharmsky #RNA #ASHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
No description available
www.cell.com
November 8, 2026 at 1:00 PM
RRIDs were included in this in Cell Reports Medicine paper. RRIDs improve reproducibility in scientific research. #reproducibility #OpenScience #accelerateopenscience
Senescent T cells within the tumor microenvironment are a potent driver for tumor growth, stemness, and chemotherapy resistance
Read the full paper: Senescent T cells within the tumor microenvironment are a potent driver for tumor growth, stemness, and chemotherapy resistance
doi.org
November 8, 2026 at 8:00 AM
The core property of cancer cells is the property of a type of normal cells: neural stemness

Understanding cancer as a systemic disease through comprehension of neural stemness as the core property of cancer cell and the basic rules it dictates
frontiersin.org/journals/cel...
November 6, 2026 at 11:56 AM
As generalized before, most cancer promoting genes are enriched in embryonic neural/neural stem cells, incl RPS6/Mtor....
They confer cancer cell with neural stemness, which determines tumorigenicity&pluripotency in cells

Conclusion does not only depend on data, but also depend on basic logic.
November 8, 2026 at 3:44 AM
Understanding
cancer cell/metastasis/complexity/therapy/resistance/immunoevasion/inverse correlation btw cancer&Alzheimer's...
as a whole
by understanding neural stemness as the core property of cancer cell
&rules it dictates
frontiersin.org/journals/cel...
November 7, 2026 at 3:59 AM
RRID:AB_1834466 from @thermofishersci.bsky.social was used by authors in their Immunity paper. We value the author's support of reproducibility. #ReproducibleResearch #BetterScience #OpenResearch
Growth factor VEGF-B sustains intestinal Tfh cell stemness to restrict Taurinivorans outgrowth and microbiota-driven obesity
Read the full paper: Growth factor VEGF-B sustains intestinal Tfh cell stemness to restrict Taurinivorans outgrowth and microbiota-driven obesity
doi.org
November 6, 2026 at 8:01 AM
Basic logic:
The core property of cancer cells is neural stemness

it confers pluripotency/plasticity&tumorigenicty in cancer cells

MYT1L promotes neuronal differentiation to limit cancer cell plasticity&inhibit tumorigencity

doi.org/10.1038/s415... doi.org/10.1038/s415...
@nature.com
Decoding the regulatory programs governing glioblastoma plasticity - Nature
Multi-omic analyses of cells from patients with glioblastoma (GB) provide insight into the role of non-genetic cellular plasticity in disease progression, showing that state stability in GB cells is c...
doi.org
November 7, 2026 at 3:52 AM
The authors included RRIDs in their in Cell & Bioscience paper! Thanks for making your methods matter! #reproducibility #OpenScience #BetterScience
α-Synuclein triggers intercellular nanotubes formation to prevent apoptosis in astroglia by promoting stemness
Read the full paper: α-Synuclein triggers intercellular nanotubes formation to prevent apoptosis in astroglia by promoting stemness
doi.org
November 5, 2026 at 8:00 AM
LEF1 and niche factors are critical in determining T cell stemness, revealing that TCF1^hi T cells are not solely stem-like in autoimmunity and chronic infection. PMID:42385703, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00709-9
No description available
www.cell.com
November 5, 2026 at 3:00 PM
Why this is an abnormality only in cancer but not normal cells?
If you know RPS6/mTOR...are embryonic neural, like most cancer promoting genes, then the abnormality features neural stemness, the property of embryonic neural cells. They are not normal?
@nature.com
www.nature.com/articles/d41...
A death sentence for ‘sloppy’ cancers
The process of making protein from RNA can go awry in cancer cells. This malfunction might be harnessed to create an effective gene-therapy tool that targets tumours.
www.nature.com
November 6, 2026 at 11:49 AM